Inhibikase Therapeutics, Inc.
IKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001750149
No open-market purchases or sales by Inhibikase Therapeutics, Inc. insiders were filed in the last 90 days; 105 institutions reported holding it in 13F filings for Q2 2026, worth $239.2M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Inhibikase Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +20 vs. Q3 2024
- Shares held
- 50.1M
- +49.2M (+5,719.3%) vs. Q3 2024
- Total value
- $162.7M
- +$161.6M (+14,447.8%) vs. Q3 2024
- New holders
- 23
- 7 more added
- Sold out
- 3
- 0 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 105 | $239.2M |
| Q1 2026 | 104 | $193.4M |
| Q4 2025 | 74 | $218.2M |
| Q3 2025 | 54 | $89.0M |
| Q2 2025 | 48 | $106.3M |
| Q1 2025 | 47 | $112.7M |
| Q4 2024 | 31 | $162.7M |
| Q3 2024 | 11 | $1.12M |
| Q2 2024 | 12 | $1.02M |
| Q1 2024 | 12 | $443.8K |
| Q4 2023 | 11 | $298.9K |
| Q3 2023 | 13 | $597.6K |
| Q2 2023 | 14 | $2.69M |
| Q1 2023 | 17 | $2.91M |
| Q4 2022 | 19 | $719.4K |
| Q3 2022 | 24 | $2.78M |
| Q2 2022 | 22 | $2.49M |
| Q1 2022 | 24 | $6.33M |
| Q4 2021 | 26 | $6.85M |
| Q3 2021 | 21 | $7.78M |
| Q2 2021 | 14 | $10.6M |
| Q1 2021 | 9 | $975.0K |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Inhibikase Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Synergy Financial Management, LLC | 50 | $65 | 0.00% | +50 | New |
| Wells Fargo & Company | 167 | $543 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 4,509 | $14.7K | 0.00% | +4,456+8,407.5% | Added |
| Morgan Stanley | 7,296 | $23.7K | 0.00% | +5,629+337.7% | Added |
| Stifel Financial Corp | 13,129 | $42.7K | 0.00% | +13,129 | New |
| Jefferies Financial Group Inc. | 14,800 | $48.1K | 0.00% | +14,800 | New |
| Alpine Global Management, LLC | 14,842 | $48.2K | 0.01% | +14,842 | New |
| Caxton Corp | 16,393 | $53.3K | 0.32% | +16,393 | New |
| UBS Group AG | 27,526 | $89.5K | 0.00% | +22,653+464.9% | Added |
| Squarepoint Ops LLC | 28,411 | $92.3K | 0.00% | +28,411 | New |
| State Street Corp | 41,884 | $136.1K | 0.00% | +31,800+315.4% | Added |
| Goldman Sachs Group Inc | 43,952 | $142.8K | 0.00% | +43,952 | New |
| HRT Financial LP | 46,416 | $150.0K | 0.00% | +46,416 | New |
| Omers Administration Corp | 54,600 | $177.4K | 0.00% | +54,600 | New |
| Northern Trust Corp | 64,011 | $208.0K | 0.00% | +64,011 | New |
| Citigroup Inc | 77,100 | $250.6K | 0.00% | +77,100 | New |
| Barclays PLC | 84,000 | $273.0K | 0.00% | +84,000 | New |
| Blair William & Co | 134,953 | $438.6K | 0.00% | +8,833+7.0% | Added |
| Millennium Management LLC | 142,209 | $462.2K | 0.00% | +142,209 | New |
| Geode Capital Management, LLC | 322,878 | $1.05M | 0.00% | +272,813+544.9% | Added |
| BlackRock, Inc. | 335,460 | $1.09M | 0.00% | +335,460 | New |
| Stonepine Capital Management, LLC | 1,132,388 | $3.68M | 2.97% | +1,132,388 | New |
| Blackstone Group Inc. | 2,070,684 | $6.73M | 0.03% | +2,070,684 | New |
| Nantahala Capital Management, LLC | 2,190,000 | $7.12M | 0.50% | +2,190,000 | New |
| Vanguard Group Inc | 2,838,645 | $9.23M | 0.00% | +2,821,921+16,873.5% | Added |
| ADAR1 Capital Management, LLC | 5,103,005 | $16.6M | 3.42% | +5,103,005 | New |
| Perceptive Advisors LLC | 5,925,000 | $19.3M | 0.54% | +5,925,000 | New |
| Commodore Capital LP | 5,925,000 | $19.3M | 1.41% | +5,925,000 | New |
| Fairmount Funds Management LLC | 6,125,000 | $19.9M | 1.98% | +6,125,000 | New |
| Soleus Capital Management, L.P. | 6,325,000 | $20.6M | 1.56% | +6,325,000 | New |
| Sands Capital Ventures, LLC | 10,950,000 | $35.6M | 7.74% | +10,950,000 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −626,500−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −19,922−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,057−100.0% | Sold out |